Rasio cepet bullfrogai.com (BFRG)

This price chart helps assess the scaling potential of the bfLeap AI system for accelerating biomedical analysis and the growth of SaaS revenues for Bullfrog AI Holdings (BFRG). Currently, the ratio stands at 10.94. The business relies on long-term licensing payments from pharma behemoths integrating the software into their research. However, this price chart also reflects negative factors: operating losses and a dependence on new equity issuances at the start of commercialization.

The stability of Bullfrog AI Holdings (BFRG) relies on sustained demand within the medical sector, making cash flow analysis critically important. This critical liquidity ratio measures the company's ability to meet short-term obligations using its most liquid assets while completely excluding slow-moving inventories, allowing investors to objectively assess real solvency and the fair value of the business.